NCT03484884View on ClinicalTrials.gov

A Study of Optical Imaging With Light From Radiotracers in Cancer Patients

Active, not recruitingOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Thyroid Cancer
Interventions
DIAGNOSTIC_TEST

Cerenkov luminescence imaging.

Cerenkov luminescence imaging will be obtained from MSKCC patients who are scheduled for routine FDG PET scan or 131I therapy that emit a continuum of ultraviolet and visible light from the decay of certain radionuclides.

Trial Locations (1)

10021

Memorial Sloan - Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03484884 - A Study of Optical Imaging With Light From Radiotracers in Cancer Patients | Biotech Hunter | Biotech Hunter